Health 29 sources · over 2 days 44 articles

FDA orders vision loss warnings for GLP-1 weight-loss and diabetes drugs

Manufacturers must warn patients and doctors about a potential increased risk of a rare eye condition that can cause permanent vision loss, affecting widely used weight-loss and diabetes medicines.

Read the full story → · Latest coverage 11 Nov 2026, 10:25 am UTC

Key moments · 8

Studies report elevated NAION risk among GLP-1 medicine users

MarketWatch ↗

FDA requires drugmakers to warn patients and doctors

STAT News ↗

Coverage reports eye condition across all GLP-1 drugs

The Hindu ↗

FDA trial analysis finds higher incidence among GLP-1 users

Mint ↗

Label changes specified for 12 GLP-1 medicines

FiercePharma ↗

FDA orders NAION warnings on GLP-1 labels

BBC World ↗

CBS discusses rare vision-loss warning for GLP-1 drugs

CBS Top Stories ↗

FDA describes possible optic nerve blood flow reduction

Business Line - Home ↗

Coverage by day

newest first

6 articles

  1. FDA flags rare vision-loss risk with GLP-1 drugs; doctors say patients need not panic
    Business Line - Home
  2. 'Ozempic made me go suddenly blind': Victim reveals devastation after losing his sight while on the jab... as health chiefs order new 'eye stroke' warning for weight-loss drugs. The symptoms every patient needs to know
    Daily Mail
  3. Taking Ozempic or Wegovy for weight loss? New regulatory warning issued
    Gulf News
  4. FDA adds vision loss warning to all GLP-1 drugs
    /r/medicine: a subreddit for medical professionals
  5. GLP-1 drugs to carry warning about rare vision-loss side effect, FDA says
    CBS Top Stories

21 articles

  1. GLP-1 drugs carry risk of rare but serious eye condition – a physician studying these medicines explains the potential side effect
    The Conversation
  2. Taking Ozempic or Wegovy? The FDA says there’s a new warning you shouldn’t ignore
    Fast Company
  3. FDA warns of rare eye condition causing blindness from GLP-1 weight loss medications - The Guardian
    The Guardian
  4. Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
    BBC World
  5. FDA to require vision loss warning on GLP-1 drug labels
    Global News

16 articles

  1. FDA tells GLP-1 makers to warn of potential vision loss side effect - The Washington Post
    The Washington Post
  2. FDA Orders New Vision Loss Warning for Ozempic and Other GLP-1s
    Gizmodo Tech
  3. FDA warns of rare ‘eye stroke’ risk from GLP-1 drugs
    The Hill
  4. GLP-1 drugs must have new warning label over incurable blindness condition, says FDA
    New York Post
  5. FDA adds rare vision-loss warning to popular GLP-1 drugs
    KYTV | KY3 | The Place to Be | First Alert Weather | Springfield, Mo | Arkansas | Missouri